Sofargen 1% 120g cream

Sofargen 1% 120 g cream it's a topical antibacterial based on silver sulfadiazine, specifically formulated for prophylaxis and local treatment of skin infections. Thanks to its targeted action, Sofargen cream is particularly suitable for the treatment of 2nd and 3rd degree burns, varicose ulcers, infected bedsores and, in general, for all skin lesions e wounds at risk of infection or already infected. The presence of silver sulfadiazine guarantees effective action against a wide spectrum of bacteria, contributing to prevent infections and to encourage healing of damaged tissues.

The cream formulation from 120 g allows one easy application on large skin surfaces, ensuring uniform and prolonged coverage. Sofargen 1% is ideal as burn cream, wound cream, sore cream and for the treatment of abrasions ed abrasions. The product is suitable for both infection prevention that for the treatment of bacterial infections already in place, proving to be an indispensable ally in the management of skin lesions at risk of infectious complications.

Thanks to his healing action and protective, Sofargen 1% cream is a medicine SOP (without prescription) for topical use, designed to offer an effective and safe solution in infection prophylaxis skin. Its composition, enriched with selected excipients, ensures good skin tolerability and rapid absorption, making it also suitable for prolonged treatments on delicate or compromised areas.

INDICATIONS

Why is Sofargen 1% 120 g cream used? What is it for?

Prophylaxis and local antibacterial treatment of infections in case of 2nd and 3rd degree burns; local antibacterial treatment of varicose ulcers and infected bedsores and in general of dermatological conditions that are infected or susceptible to superinfections.

ACTIVE INGREDIENTS AND EXCIPIENTS

What is the composition of Sofargen 1% 120 g cream?

Composition

Sofargen 1% cream contains 1 g of micronized silver sulfadiazine. Excipients with known effects: stearyl alcohol, propylene glycol, methyl p-oxybenzoate. For the complete list of excipients

Excipients

Stearyl alcohol; isopropyl myristate; propylene glycol; polyethylene glycol monostearate; polyoxyethylene sorbitan monolaurate; methyl-p-oxybenzoate; distilled water.

DOSAGE

How to take Sofargen 1% 120 g cream?

In burns Sofargen should be applied as early as possible. After a quick cleansing of the injured parts, immediately spread a uniform layer of cream 2 or 3 mm thick on the burnt surfaces. The cream can be applied either directly to the lesions, possibly with the help of a sterile glove, or previously spread on sterile gauze. The application of Sofargen must continue without interruption, once or twice a day, as long as there is a possibility of infection and until complete healing, both in spontaneous and surgical repairs. At each renewal of the dressing, carefully cleanse the wounds with water or physiological solution by showering or sponging. Take care to promptly reapply the cream on surfaces from which it has been inadvertently removed. In other cases, varicose ulcers, bedsores, wounds and dermatological conditions susceptible to infection, cleanse the injured part where necessary and apply a layer of cream 2-3 mm thick, following the same criterion described for the treatment of burns. The lesion must always be kept completely covered by the medicine. If a knee-high type dressing is needed, unwrap 20-30 cm portions of a bandage of adequate length, spread a generous layer of cream, rewrap the impregnated part, unwrap another 20-30 cm and repeat the operation until the entire length of the bandage has been completely impregnated, then apply the required bandage.

CONTRAINDICATIONS AND SIDE EFFECTS

When should Sofargen 1% 120 g cream not be used and what side effects can it cause?

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Since sulphonamides may increase the risk of neonatal jaundice, Sofargen should not be used in women at the end of pregnancy, in premature babies and in newborns in the first months of life.

Side effects

Some cases of transient leukopenia (0.4%), rare local disorders (pain and burning) and rare local allergic reactions (0.3%) have been reported. The classic side effects of systemically administered sulphonamides cannot be excluded when treating large parts of the body. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

INTERACTIONS

Which medicines or foods can change the effect of Sofargen 1% 120 g cream?

Local proteolytic enzymes, applied simultaneously with Sofargen, can be inactivated by the presence of silver ions.

PREGNANCY AND BREASTFEEDING

Can Sofargen 1% 120 g cream be used during pregnancy and breastfeeding?

Since there is no exhaustive experimental data on the possible effects of the drug on the fetus, Sofargen should not be used during pregnancy and breastfeeding unless, in the opinion of the doctor, its use is indispensable and essential for the pregnant woman (see 4.3).

WARNINGS

What are the warnings of Sofargen 1% 120 g cream?

Warnings and precautions

Sofargen should be applied with caution in the presence of hepatic or renal insufficiency. The use of Sofargen may be risky in subjects with manifest glucose,6,phosphate dehydrogenase deficiency, as hemolytic phenomena may occur. Prolonged use of the product may give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and adopt suitable therapeutic measures. The same applies in case of superinfection by resistant microorganisms. In the treatment of burns of a large part of the body, serum concentrations of sulphonamide can reach therapeutic levels in adults. Therefore, in these patients it would be advisable to monitor these serum levels, renal function, the presence of any sulphonamide crystals in the urine and liver function, interrupting therapy if liver and/or renal function is compromised. Furthermore, given that propylene glycol, present as an excipient in the composition, can cause hyperosmolality when the product is applied to large burn areas, serum osmolality must be periodically checked and, if necessary, the treatment must be interrupted.

Overdose

No symptoms of overdose have been highlighted in the literature.

Driving vehicles and using machinery

Sofargen does not affect the ability to drive or use machines.

CONSERVATION

How is Sofargen 1% 120 g cream stored?

Store at temperatures below 30° C. The product must be used within 6 months of first opening the container.

FORMAT

What is the format of Sofargen 1% 120 g cream?

DRUG LEGAL TEXT

Content responsibility

This sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note

The product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.

Data source: Farmadati Italia

Website: www.farmadati.it

The Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.

The Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.